TAB Becket Invest Plc

RNS No 4287h
THERAPEUTIC ANTIBODIES INC
9th November 1998



Schedule 11 - Notification of interests of Directors and Connected Persons

1   Name of company:
THERAPEUTIC ANTIBODIES INC

2   Name of director:
MARTIN S BROWN

3   Please state whether notification indicates that it is in respect of     
holding of the director named in 2 above or holding of that person's spouse or
children under the age of 18 or in respect of a non- beneficial interest:
DIRECTOR NAMED IN 2 ABOVE

4   Name of registered holder(s) and, if more than one holder, the number of 
shares held by each of them (if notified):
MARTIN S BROWN

5   Please state whether notification relates to a person(s) connected with  
the director named in 2 above and identify the connected person(s):
N/A

6   Please state the nature of the transaction. For PEP transactions please  
indicate whether general/single co PEP and if discretionary/non discretionary:
CONVERSION OF 15% LOAN NOTES INTO EQUITY

7   Number of shares/amount of stock acquired:
392,780

8   Percentage of issued class:
0.75%

9   Number of shares/amount of stock disposed:
-

10  Percentage of issued class:
-

11  Class of security:
SHARES OF COMMON STOCK OF US$0.001

12  Price per share:
40p

13  Date of transaction:
9.11.98

14  Date company informed:
9.11.98

15  Total holding following this notification:
3,024,413

16  Total percentage holding of issued class following this notification:
5.81%

If a director has been granted options by the company, please complete the
following fields:

17  Date of grant:
-

18  Period during which or date on which exercisable:
-

19  Total amount paid (if any) for grant of the option:
-

20  Description of shares or debentures involved: class, number:
-

21  Exercise price (if fixed at time of grant) or indication that price is to
be fixed at time of exercise:
-

22  Total number of shares or debentures over which options held following
this notification:
-

23  Contact name for queries:
SAUL KOMISAR

24  Contact telephone number:
001 615 963 4529

25  Name of company official responsible for making notification:
PHIL WALKER




Schedule 11 - Notification of interests of Directors and Connected Persons

1   Name of company:
THERAPEUTIC ANTIBODIES INC

2   Name of director:
ANDREW J HEATH

3   Please state whether notification indicates that it is in respect of     
holding of the director named in 2 above or holding of that person's spouse or
children under the age of 18 or in respect of a non- beneficial interest:
DIRECTOR NAMED IN 2 ABOVE

4   Name of registered holder(s) and, if more than one holder, the number of 
shares held by each of them (if notified):
ANDREW J HEATH

5   Please state whether notification relates to a person(s) connected with  
the director named in 2 above and identify the connected person(s):
N/A

6   Please state the nature of the transaction. For PEP transactions please  
indicate whether general/single co PEP and if discretionary/non discretionary:
36,840 BY PARTICIPATION IN THE PLACING AND 196,390 BY CONVERSION OF 15% LOAN
NOTE INTO EQUITY

7   Number of shares/amount of stock acquired:
233,230

8   Percentage of issued class:
0.45%

9   Number of shares/amount of stock disposed:
-

10  Percentage of issued class:
-

11  Class of security:
SHARES OF COMMON STOCK OF US$0.001

12  Price per share:
40p

13  Date of transaction:
9.11.98

14  Date company informed:
9.11.98

15  Total holding following this notification:
248,230

16  Total percentage holding of issued class following this notification:
0.48%

If a director has been granted options by the company, please complete the
following fields:

17  Date of grant:
-

18  Period during which or date on which exercisable:
-

19  Total amount paid (if any) for grant of the option:
-

20  Description of shares or debentures involved: class, number:
-

21  Exercise price (if fixed at time of grant) or indication that price is to
be fixed at time of exercise:
-

22  Total number of shares or debentures over which options held following
this notification:
-

23  Contact name for queries:
SAUL KOMISAR

24  Contact telephone number:
001 615 963 4529

25  Name of company official responsible for making notification:
PHIL WALKER




Schedule 11 - Notification of interests of Directors and Connected Persons

1   Name of company:
THERAPEUTIC ANTIBODIES INC

2   Name of director:
STUART WALLIS

3   Please state whether notification indicates that it is in respect of     
holding of the director named in 2 above or holding of that person's spouse or
children under the age of 18 or in respect of a non- beneficial interest:
DIRECTOR NAMED IN 2 ABOVE

4   Name of registered holder(s) and, if more than one holder, the number of 
shares held by each of them (if notified):
STUART WALLIS

5   Please state whether notification relates to a person(s) connected with  
the director named in 2 above and identify the connected person(s):
N/A

6   Please state the nature of the transaction. For PEP transactions please  
indicate whether general/single co PEP and if discretionary/non discretionary:
PARTICIPATION IN THE PLACING

7   Number of shares/amount of stock acquired:
375,000

8   Percentage of issued class:
0.72%

9   Number of shares/amount of stock disposed:
-

10  Percentage of issued class:
-

11  Class of security:
SHARES OF COMMON STOCK OF US$0.001

12  Price per share:
40p

13  Date of transaction:
9.11.98

14  Date company informed:
9.11.98

15  Total holding following this notification:
375,000

16  Total percentage holding of issued class following this notification:
0.72%

If a director has been granted options by the company, please complete the
following fields:

17  Date of grant:
-

18  Period during which or date on which exercisable:
-

19  Total amount paid (if any) for grant of the option:
-

20  Description of shares or debentures involved: class, number:
-

21  Exercise price (if fixed at time of grant) or indication that price is to
be fixed at time of exercise:
-

22  Total number of shares or debentures over which options held following
this notification:
-

23  Contact name for queries:
SAUL KOMISAR

24  Contact telephone number:
001 615 963 4529

25  Name of company official responsible for making notification:
PHIL WALKER


Additional Information:


END

RDAALLVDLELAIAT

Becket Invest (LSE:TAB)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024

Becket Invest (LSE:TAB)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024